Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trial in EJC SUPPLEMENTS, vol 8, issue 3, pp 195-196

Hatschek, T (author)

Karolinska University Hospital

Einbeigi, Z (author)

Sahlgrens University Hospital

Walz, Thomas (author)

Östergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US

show more...

Malmberg, M (author)

Helsingborg Hospital

Loman, N (author)

Lund University Hospital

Carlsson, L (author)

Sundsvall Hospital

Soderberg, M (author)

Malmo University Hospital

Linderholm, B (author)

Sahlgrens University Hospital

Lindh, B (author)

Norrland University Hospital

Sundqvist, M (author)

Kalmar Hospital

show less...

 (creator_code:org_t)

Elsevier Science B.V., Amsterdam. 2010

2010

English.

In: EJC SUPPLEMENTS. - : Elsevier Science B.V., Amsterdam.. ; , s. 195-196

Related links:

https://urn.kb.se/re...

• Conference paper (peer-reviewed)